Aspen Aerogels, Inc.ASPNNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank82
5Y CAGR+4.2%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
+4.2%/yr
Long-term compound
Percentile
P82
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202512.07%
Q3 2025-34.26%
Q2 2025-12.44%
Q1 2025-1.63%
Q4 2024-4.05%
Q3 20240.57%
Q2 20241.69%
Q1 202410.16%
Q4 2023-3.39%
Q3 20236.41%
Q2 2023-3.29%
Q1 2023-2.34%
Q4 2022-10.59%
Q3 20225.55%
Q2 202223.80%
Q1 20228.42%
Q4 20217.67%
Q3 202117.94%
Q2 20216.84%
Q1 20216.50%
Q4 20209.82%
Q3 2020-1.56%
Q2 2020-4.76%
Q1 2020-13.18%
Q4 201925.37%
Q3 20199.53%
Q2 2019-3.11%
Q1 201913.95%
Q4 201822.25%
Q3 2018-15.51%
Q2 20182.06%
Q1 201812.47%
Q4 2017-2.79%
Q3 2017-14.10%
Q2 20178.44%
Q1 201714.04%
Q4 20164.07%
Q3 20163.27%
Q2 2016-1.83%
Q1 20164.63%